Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The cancer exome generated by alternative mRNA splicing dilutes predicted HLA class I epitope density.

Stranzl T, Larsen MV, Lund O, Nielsen M, Brunak S.

PLoS One. 2012;7(9):e38670. doi: 10.1371/journal.pone.0038670. Epub 2012 Sep 25.

2.

Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.

Azuma K, Sasada T, Takedatsu H, Shomura H, Koga M, Maeda Y, Yao A, Hirai T, Takabayashi A, Shichijo S, Itoh K.

Clin Cancer Res. 2004 Oct 1;10(19):6695-702.

3.

Molecular characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159).

Lazaro E, Tram LT, Bellecave P, Guidicelli GL, Anies G, Thu HH, Debelleix MP, Vray M, Recordon-Pinson P, Taupin JL, Lien TT, Fleury H.

PLoS One. 2011;6(10):e26244. doi: 10.1371/journal.pone.0026244. Epub 2011 Oct 19.

6.

HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies.

Ravindranath MH, Taniguchi M, Chen CW, Ozawa M, Kaneku H, El-Awar N, Cai J, Terasaki PI.

Mol Immunol. 2010 Feb;47(5):1121-31. doi: 10.1016/j.molimm.2009.10.024. Epub 2009 Nov 26.

PMID:
19944464
7.

Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides.

Pala P, Corradin G, Strachan T, Sodoyer R, Jordan BR, Cerottini JC, Maryanski JL.

J Immunol. 1988 Feb 1;140(3):871-7.

PMID:
2448379
8.
9.

HLA class I allele promiscuity revisited.

Rao X, Hoof I, Costa AI, van Baarle D, Keşmir C.

Immunogenetics. 2011 Nov;63(11):691-701. doi: 10.1007/s00251-011-0552-6. Epub 2011 Jun 22.

10.

Impact of alternative initiation, splicing, and termination on the diversity of the mRNA transcripts encoded by the mouse transcriptome.

Zavolan M, Kondo S, Schonbach C, Adachi J, Hume DA, Hayashizaki Y, Gaasterland T; RIKEN GER Group; GSL Members.

Genome Res. 2003 Jun;13(6B):1290-300.

11.

Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles.

Bachinsky MM, Guillen DE, Patel SR, Singleton J, Chen C, Soltis DA, Tussey LG.

Cancer Immun. 2005 Mar 22;5:6.

12.

An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.

Nielsen JS, Wick DA, Tran E, Nelson BH, Webb JR.

J Immunol Methods. 2010 Aug 31;360(1-2):149-56. doi: 10.1016/j.jim.2010.07.003. Epub 2010 Jul 15.

PMID:
20637775
13.

Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.

Klyushnenkova EN, Kouiavskaia DV, Kodak JA, Vandenbark AA, Alexander RB.

Prostate. 2007 Jul 1;67(10):1019-28.

PMID:
17455230
14.

Immunodominance across HLA polymorphism: implications for cancer immunotherapy.

Kim CJ, Parkinson DR, Marincola F.

J Immunother. 1998 Jan;21(1):1-16. Review.

PMID:
9456431
15.

Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa.

Honeyborne I, Rathod A, Buchli R, Ramduth D, Moodley E, Rathnavalu P, Chetty S, Day C, Brander C, Hildebrand W, Walker BD, Kiepiela P, Goulder PJ.

J Immunol. 2006 Apr 15;176(8):4699-705.

16.

Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.

Rolland M, Heckerman D, Deng W, Rousseau CM, Coovadia H, Bishop K, Goulder PJ, Walker BD, Brander C, Mullins JI.

PLoS One. 2008 Jan 9;3(1):e1424. doi: 10.1371/journal.pone.0001424.

17.

Identification of T cell epitopes by the use of rapidly generated mRNA fragments.

Britten CM, Meyer RG, Graf C, Huber C, Wölfel T.

J Immunol Methods. 2005 Apr;299(1-2):165-75. Epub 2005 Mar 31.

PMID:
15914199
18.

HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.

Alvarez MG, Postan M, Weatherly DB, Albareda MC, Sidney J, Sette A, Olivera C, Armenti AH, Tarleton RL, Laucella SA.

PLoS Negl Trop Dis. 2008;2(9):e288. doi: 10.1371/journal.pntd.0000288. Epub 2008 Sep 3.

19.

Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation.

Bassani-Sternberg M, Pletscher-Frankild S, Jensen LJ, Mann M.

Mol Cell Proteomics. 2015 Mar;14(3):658-73. doi: 10.1074/mcp.M114.042812. Epub 2015 Jan 9.

20.

Supplemental Content

Support Center